Thoroughbred Financial Services LLC purchased a new stake in shares of UnitedHealth Group Inc (NYSE:UNH) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 6,390 shares of the healthcare conglomerate’s stock, valued at approximately $1,591,000.
Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Fagan Associates Inc. boosted its stake in UnitedHealth Group by 2.7% in the 4th quarter. Fagan Associates Inc. now owns 1,433 shares of the healthcare conglomerate’s stock worth $357,000 after purchasing an additional 38 shares during the period. Advisors Capital Management LLC boosted its stake in UnitedHealth Group by 3.0% in the 4th quarter. Advisors Capital Management LLC now owns 1,480 shares of the healthcare conglomerate’s stock worth $369,000 after purchasing an additional 43 shares during the period. NewSquare Capital LLC boosted its stake in UnitedHealth Group by 15.6% in the 4th quarter. NewSquare Capital LLC now owns 333 shares of the healthcare conglomerate’s stock worth $83,000 after purchasing an additional 45 shares during the period. SWS Partners boosted its stake in UnitedHealth Group by 1.9% in the 4th quarter. SWS Partners now owns 2,446 shares of the healthcare conglomerate’s stock worth $609,000 after purchasing an additional 45 shares during the period. Finally, Capital Investment Advisors LLC boosted its stake in UnitedHealth Group by 0.9% in the 4th quarter. Capital Investment Advisors LLC now owns 5,389 shares of the healthcare conglomerate’s stock worth $1,343,000 after purchasing an additional 48 shares during the period. 86.68% of the stock is owned by hedge funds and other institutional investors.
Several research analysts have weighed in on UNH shares. Zacks Investment Research downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Tuesday, March 19th. Oppenheimer increased their target price on UnitedHealth Group from $300.00 to $305.00 and gave the company an “outperform” rating in a research report on Wednesday, January 16th. ValuEngine downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Wednesday, February 27th. Cantor Fitzgerald reiterated a “buy” rating and set a $310.00 target price on shares of UnitedHealth Group in a research report on Tuesday, January 15th. Finally, Stephens started coverage on UnitedHealth Group in a research report on Monday, January 14th. They set an “overweight” rating and a $287.00 target price for the company. Three investment analysts have rated the stock with a hold rating and twenty have given a buy rating to the company. The stock presently has a consensus rating of “Buy” and an average price target of $297.80.
UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $3.73 earnings per share for the quarter, topping analysts’ consensus estimates of $3.60 by $0.13. UnitedHealth Group had a return on equity of 24.38% and a net margin of 5.30%. The business had revenue of $60.30 billion for the quarter, compared to analyst estimates of $59.72 billion. During the same quarter last year, the firm posted $3.04 earnings per share. The business’s revenue was up 9.2% compared to the same quarter last year. On average, sell-side analysts anticipate that UnitedHealth Group Inc will post 14.63 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were paid a $0.90 dividend. The ex-dividend date of this dividend was Friday, March 8th. This represents a $3.60 dividend on an annualized basis and a yield of 1.63%. UnitedHealth Group’s payout ratio is 27.95%.
In other news, Director Richard T. Burke sold 5,000 shares of the firm’s stock in a transaction on Tuesday, March 19th. The stock was sold at an average price of $257.32, for a total transaction of $1,286,600.00. Following the transaction, the director now owns 182,454 shares in the company, valued at $46,949,063.28. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Gail R. Wilensky sold 2,930 shares of the firm’s stock in a transaction on Thursday, March 14th. The shares were sold at an average price of $253.39, for a total value of $742,432.70. Following the transaction, the director now owns 64,726 shares in the company, valued at approximately $16,400,921.14. The disclosure for this sale can be found here. In the last quarter, insiders sold 32,930 shares of company stock worth $8,495,383. Insiders own 0.87% of the company’s stock.
WARNING: This story was originally posted by Markets Daily and is the property of of Markets Daily. If you are viewing this story on another domain, it was illegally stolen and republished in violation of United States and international trademark & copyright law. The correct version of this story can be viewed at https://www.themarketsdaily.com/2019/04/17/6390-shares-in-unitedhealth-group-inc-unh-acquired-by-thoroughbred-financial-services-llc.html.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Featured Article: Trading Options- What is a Strangle?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.